Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hologic Inc (NASDAQ:HOLX)

35.90
Delayed Data
As of Oct 16
 -0.38 / -1.05%
Today’s Change
35.15
Today|||52-Week Range
46.80
-10.52%
Year-to-Date
3 Plastic & Reconstructive Surgery Stocks Looking Good
Oct 11 / Zacks.com - Paid Partner Content
Hologic's Panther Fusion Flu A/B/RSV Assay Gets FDA Approval
Oct 06 / Zacks.com - Paid Partner Content
Jerome Dodson Starts 5 New Positions in 3rd Quarter
Oct 10 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close36.28
Today’s open36.31
Day’s range35.78 - 36.46
Volume5,243,508
Average volume (3 months)2,998,279
Market cap$10.2B
Dividend yield--
Data as of 4:14pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+157.78%
Earnings growth (this year)+2.46%
Earnings growth (next 5 years)+8.41%
Revenue growth (last year)+4.72%
P/E ratio13.4
Price/Sales3.88
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
VREXVarex Imaging Corp+0.08+0.24%
ALOGAnalogic Corp-0.35-0.43%
GTHPGuided Therapeutics ...+0.00+2.56%
Data as of 3:59pm ET, 10/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$2.8B
Annual profit (last year)$330.8M
Net profit margin11.68%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Stephen P. MacMillan
Chief Operating Officer
Eric B. Compton
Corporate headquarters
Marlborough, Massachusetts

Forecasts